Tracked deals
17
17 tracked deals across 2013-2026.
Boston, Massachusetts, United States
THL Partners is a Boston-based private equity firm investing in middle-market growth companies across Financial Technology & Services, Healthcare, and Technology & Business Solutions. The firm partners with management teams and uses internal operating resources to transform and build companies of lasting value.
Tracked deals
17
17 tracked deals across 2013-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
7 buyout · 5 growth capital · 3 recapitalization
Last 7 years
Supporting Data
Showing the 12 most recent of 17 tracked deals for THL Partners.
Queue-it entered a definitive agreement for THL Partners to make a majority investment in the company. The partnership is intended to accelerate product innovation and expand Queue-it’s global reach for its online traffic orchestration platform.
THL Partners is acquiring a majority stake in Celerion Holdings, Inc. for approximately $1.8 billion from funds affiliated with H.I.G. Capital. The deal is focused on advancing Celerion’s clinical pharmacology and bioanalytical capabilities, with completion expected in 2026 subject to customary conditions and regulatory approval.
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
THL Partners has agreed to acquire a majority stake in AMI from HGGC in a private transaction expected to close in fall/Q4 2024. AMI, headquartered in Duluth, Georgia, is a global leader in dynamic firmware used across data centers and cloud platforms and employs over 1,500 engineers; THL says the investment will accelerate product innovation and market expansion to address growing AI and hyperscale infrastructure demand.
THL Partners has agreed to make a majority investment in YA Group, a Nashville-based professional services firm providing forensic consulting, engineering, and risk mitigation services to insurance and public-sector clients. Current investor CIVC Partners, management and employees will retain significant ownership, and the capital will be used to accelerate organic growth, expand core capabilities and pursue strategic acquisitions.
Smile Doctors, a PE-backed orthodontic support organization, has acquired Grinz Orthodontics. The deal adds Grinz's practices in North Carolina and Arizona to Smile Doctors' network; Smile Doctors is a portfolio company of Linden Capital Partners and Thomas H. Lee Partners.
Thomas H. Lee Partners (THL) has made a strategic growth investment in Carpe Data, becoming the majority shareholder while the company's founders, management and existing strategic investors retain meaningful stakes. The investment will fund continued innovation in Carpe Data's AI-driven alternative data platform for insurance and support expansion across core segments and adjacent markets.
Thomas H. Lee Partners (THL) has agreed to acquire a majority interest in Intelligent Medical Objects (IMO) from Warburg Pincus. THL's investment will support IMO's product development and expansion of commercial relationships with hospitals, physicians and other healthcare organizations.
Qventus announced a $50 million growth capital round led by Thomas H. Lee Partners with a strategic partnership and investment from Premier, Inc.; ThedaCare and existing investors Bessemer Venture Partners, Mayfield, and Norwest Venture Partners also participated. The funding and partnership will help Qventus expand its AI-powered care-operations platform across additional hospitals and health systems and enable product enhancements that leverage Premier’s data assets.
Smile Doctors, the largest U.S. orthodontics-focused dental support organization with more than 295 locations, announced a strategic investment from Thomas H. Lee Partners. THL is investing alongside existing sponsor Linden Capital Partners in an equal partnership while affiliated orthodontists retain a significant ownership stake to support continued growth and expanded service offerings.
Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.
Thomas H. Lee Partners (THL) has made a strategic growth investment in Odessa, a Philadelphia-based provider of asset finance and leasing software. The investment will fund Odessa's platform roadmap, capability expansion across financial services, geographic growth (U.S. and international), and potential M&A activity to accelerate product and market expansion.
Turn tracked acquisition activity into an outreach-ready buyer list.